Table of Contents Author Guidelines Submit a Manuscript
Volume 2, Pages 791-800
Mini-Review Article

Pharmacogenetics of Antiplatelet Drugs

Department of Clinical Pharmacology, Royal College of Surgeons in Ireland, 123 St. Stephen’s Green, Dublin 2, Ireland

Received 7 December 2001; Revised 1 February 2002; Accepted 21 March 2002

Copyright © 2002 Ronan Curtin and Desmond J. Fitzgerald.

Citations to this Article [4 citations]

The following is the list of published articles that have cited the current article.

  • P. Fontana, and J.-L. Reny, “Pharmacogenetics and antiplatelet drugs,” Revue de Medecine Interne, vol. 26, no. 9, pp. 725–732, 2005. View at Publisher · View at Google Scholar
  • Elijah Saunders, and Elizabeth Ofili, “Epidemiology of Atherothrombotic Disease and the Effectiveness and Risks of Antiplatelet Therapy,” Cardiology in Review, vol. 16, no. 2, pp. 82–88, 2008. View at Publisher · View at Google Scholar
  • Jeffrey D. Greenberg, and Bruce N. Cronstein, “Pharmacogenomics in rheumatology,” Rheumatology, pp. 205–210.e2, 2011. View at Publisher · View at Google Scholar
  • D. Saadoun, J.-C. Piette, D. Wahl, and N. Costedoat-Chalumeau, “Traitement du syndrome des anticorps antiphospholipides,” La Revue de Médecine Interne, vol. 33, no. 4, pp. 217–222, 2012. View at Publisher · View at Google Scholar